France’s Ipsen will get a manufacturing foothold in the U.S. with a new deal to expand its oncology reach in the country.

India’s Aurobindo Pharma, which has been building its presence around the world, has struck a new deal to buy a generics manufacturer and plant in Portugal…

Canadian generic producer Apotex has a new recall to deal with, this time for nearly 50,000 bottles of a diuretic.

Aptevo believes manufacturing issues that interrupted production of its coagulation factor IX treatment for hemophilia B have been solved and it expects to…

The FDA has issued a warning letter to a Wockhardt plant in India whose problems have leached into a CRL issued to U.S. biotech Cempra.

The FDA this year delayed the approval of six new drugs this year because of manufacturing matters, five of which were the subject of complete response letters…

PL Developments, a specialist of private label OTC products, will build a second manufacturing site in South Carolina, adding up to 450 jobs when it is…

A £120 million biologics plant to make cancer meds for the U.K. drugmaker is now online.

South San Francisco-based Portola Pharmaceuticals has snagged $50 million in loans from Pfizer and Bristol-Myers Squibb to help cover the additional costs tied…

Supply Chain